3/27/25 :: VROCKSTAR :: 
NVO
obvious at $70... 10% size
- at btc conf in miami so have been hoping for a quiet week. well. whatever. another day in trumptopia. but alas, we can't tell the market what we want. so the game today is just don't make big mistakes and try and find interesting asymmetric oppties.
- i literally flipped my NVO after last post two days in and as it proceeded to rip into $80s thought "well shoot, at least i made $, which is the goal... but i paper hands that one"
- but we're back. even lower. $70.
- wegovey vs. ozempic... these 18x PE multiples r hitting that penjamin like it's going outta style.
- when i look at LLY, which is ostensibly the mkt's "favorite" in the GLP/weight loss category it's hard to ignore the fact that financials MORE OR LESS are similar and multiples are 2x higher.
- so while idk if tariffs, the euros who trade a bit more scared, greenland stuffs, GLP "share" question marks etc. etc. are affecting the day to day.
- but at nearly 4% fcf yield, ROICs akin to the biggest tech moats, orthogonal to US/chips correlation (nevermind the geo), drugs like this being secular winners (and these guys do have pole positions)... it's pretty obvious again.
- have started to play some of the 2027 ITM expires leveraged anywhere from 2 to 3-1 so i don't need to neck out. ideally we get one more flush to the mid 60s and i can really size this up. but honestly, this is a pretty obvious LT buy zone and i'll adjust the strike accordingly based on the ST day to day.
- what chu think anon? wegovey and chill?
V
NVOobvious at $70... 10% size
- at btc conf in miami so have been hoping for a quiet week. well. whatever. another day in trumptopia. but alas, we can't tell the market what we want. so the game today is just don't make big mistakes and try and find interesting asymmetric oppties.
- i literally flipped my NVO after last post two days in and as it proceeded to rip into $80s thought "well shoot, at least i made $, which is the goal... but i paper hands that one"
- but we're back. even lower. $70.
- wegovey vs. ozempic... these 18x PE multiples r hitting that penjamin like it's going outta style.
- when i look at LLY, which is ostensibly the mkt's "favorite" in the GLP/weight loss category it's hard to ignore the fact that financials MORE OR LESS are similar and multiples are 2x higher.
- so while idk if tariffs, the euros who trade a bit more scared, greenland stuffs, GLP "share" question marks etc. etc. are affecting the day to day.
- but at nearly 4% fcf yield, ROICs akin to the biggest tech moats, orthogonal to US/chips correlation (nevermind the geo), drugs like this being secular winners (and these guys do have pole positions)... it's pretty obvious again.
- have started to play some of the 2027 ITM expires leveraged anywhere from 2 to 3-1 so i don't need to neck out. ideally we get one more flush to the mid 60s and i can really size this up. but honestly, this is a pretty obvious LT buy zone and i'll adjust the strike accordingly based on the ST day to day.
- what chu think anon? wegovey and chill?
V
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.